Chemotherapy of small-cell lung cancer

F. Anthony Greco, David H. Johnson, John D. Hainsworth, Steven N. Wolff

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Combination chemotherapy has become the cornerstone of management for patients with small-cell lung cancer. Although the majority of patients are palliated, most continue to die of their disease. Studies designed to improve treatment results and to understand the basic biology of this neoplasm are continuing. Several strategies are now being investigated, including the use of non-cross-resistant chemotherapy, dose intensification, manipulation of the duration of therapy, combined modality therapy, and salvage chemotherapy. Studies in these areas have not yet yielded results that have definitively improved response rates or survival. It appears that further therapy after remission induction has not yet proven beneficial. This paper will review selected areas of therapeutic investigation.

Original languageEnglish (US)
Pages (from-to)31-37
Number of pages7
JournalSeminars in Oncology
Volume12
Issue number4 SUPPL. 6
StatePublished - 1985

Fingerprint

Small Cell Lung Carcinoma
Drug Therapy
Musculoskeletal Manipulations
Remission Induction
Combined Modality Therapy
Combination Drug Therapy
Therapeutics
Survival Rate
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Greco, F. A., Johnson, D. H., Hainsworth, J. D., & Wolff, S. N. (1985). Chemotherapy of small-cell lung cancer. Seminars in Oncology, 12(4 SUPPL. 6), 31-37.

Chemotherapy of small-cell lung cancer. / Greco, F. Anthony; Johnson, David H.; Hainsworth, John D.; Wolff, Steven N.

In: Seminars in Oncology, Vol. 12, No. 4 SUPPL. 6, 1985, p. 31-37.

Research output: Contribution to journalArticle

Greco, FA, Johnson, DH, Hainsworth, JD & Wolff, SN 1985, 'Chemotherapy of small-cell lung cancer', Seminars in Oncology, vol. 12, no. 4 SUPPL. 6, pp. 31-37.
Greco FA, Johnson DH, Hainsworth JD, Wolff SN. Chemotherapy of small-cell lung cancer. Seminars in Oncology. 1985;12(4 SUPPL. 6):31-37.
Greco, F. Anthony ; Johnson, David H. ; Hainsworth, John D. ; Wolff, Steven N. / Chemotherapy of small-cell lung cancer. In: Seminars in Oncology. 1985 ; Vol. 12, No. 4 SUPPL. 6. pp. 31-37.
@article{6d8134ed5cf24ff9b8271c9c491f8183,
title = "Chemotherapy of small-cell lung cancer",
abstract = "Combination chemotherapy has become the cornerstone of management for patients with small-cell lung cancer. Although the majority of patients are palliated, most continue to die of their disease. Studies designed to improve treatment results and to understand the basic biology of this neoplasm are continuing. Several strategies are now being investigated, including the use of non-cross-resistant chemotherapy, dose intensification, manipulation of the duration of therapy, combined modality therapy, and salvage chemotherapy. Studies in these areas have not yet yielded results that have definitively improved response rates or survival. It appears that further therapy after remission induction has not yet proven beneficial. This paper will review selected areas of therapeutic investigation.",
author = "Greco, {F. Anthony} and Johnson, {David H.} and Hainsworth, {John D.} and Wolff, {Steven N.}",
year = "1985",
language = "English (US)",
volume = "12",
pages = "31--37",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "4 SUPPL. 6",

}

TY - JOUR

T1 - Chemotherapy of small-cell lung cancer

AU - Greco, F. Anthony

AU - Johnson, David H.

AU - Hainsworth, John D.

AU - Wolff, Steven N.

PY - 1985

Y1 - 1985

N2 - Combination chemotherapy has become the cornerstone of management for patients with small-cell lung cancer. Although the majority of patients are palliated, most continue to die of their disease. Studies designed to improve treatment results and to understand the basic biology of this neoplasm are continuing. Several strategies are now being investigated, including the use of non-cross-resistant chemotherapy, dose intensification, manipulation of the duration of therapy, combined modality therapy, and salvage chemotherapy. Studies in these areas have not yet yielded results that have definitively improved response rates or survival. It appears that further therapy after remission induction has not yet proven beneficial. This paper will review selected areas of therapeutic investigation.

AB - Combination chemotherapy has become the cornerstone of management for patients with small-cell lung cancer. Although the majority of patients are palliated, most continue to die of their disease. Studies designed to improve treatment results and to understand the basic biology of this neoplasm are continuing. Several strategies are now being investigated, including the use of non-cross-resistant chemotherapy, dose intensification, manipulation of the duration of therapy, combined modality therapy, and salvage chemotherapy. Studies in these areas have not yet yielded results that have definitively improved response rates or survival. It appears that further therapy after remission induction has not yet proven beneficial. This paper will review selected areas of therapeutic investigation.

UR - http://www.scopus.com/inward/record.url?scp=0022343482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022343482&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 31

EP - 37

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 4 SUPPL. 6

ER -